Sodium Sulfide 1% Gel Ingrown Toenail Safety Shown By Schering-Plough
This article was originally published in The Tan Sheet
Executive Summary
Sodium sulfide 1% gel could be included in the OTC monograph for ingrown toenail relief drugs following a public comment period, FDA tells Schering-Plough HealthCare Products in a May 22 letter.
You may also be interested in...
Ingrown Toenail Treatment Use With Retainer Ring System Proposed By FDA
Sodium sulfide 1% gel is safe and effective for OTC treatment of ingrown toenail pain only when used with a retainer ring system to keep the product at the area of application, FDA says in a 1proposed rule published in the Federal Register Oct. 4
Sodium Sulfide 1% Gel Safety Supported By New Clinical Data - Schering
The safety of sodium sulfide gel for the relief of pain associated with ingrown toenails is exhibited by the results of a clinical study conducted by Schering-Plough, the company tells FDA in an Oct. 13 citizen petition. Previous agency concerns regarding the ingredient's safety should be addressed by the findings, the petition says.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC